News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
621,772 Results
Type
Article (58837)
Company Profile (187)
Press Release (562748)
Section
Business (169702)
Career Advice (1837)
Deals (28968)
Drug Delivery (96)
Drug Development (65762)
Employer Resources (150)
FDA (14349)
Job Trends (13766)
News (285605)
Policy (27978)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2902)
Academic (2)
Accelerated approval (2)
Adcomms (15)
Allergies (73)
Alliances (47708)
ALS (73)
Alzheimer's disease (1292)
Antibody-drug conjugate (ADC) (93)
Approvals (14392)
Artificial intelligence (243)
Autoimmune disease (11)
Automation (14)
Bankruptcy (222)
Best Places to Work (11210)
BIOSECURE Act (13)
Biosimilars (86)
Biotechnology (109)
Bladder cancer (48)
Brain cancer (22)
Breast cancer (220)
Cancer (1728)
Cardiovascular disease (135)
Career advice (1546)
Career pathing (25)
CAR-T (122)
Cell therapy (350)
Cervical cancer (15)
Clinical research (52363)
Collaboration (750)
Compensation (179)
Complete response letters (10)
COVID-19 (2617)
CRISPR (35)
C-suite (183)
Cystic fibrosis (81)
Data (1732)
Decentralized trials (2)
Denatured (19)
Depression (36)
Diabetes (214)
Diagnostics (6346)
Digital health (19)
Diversity (7)
Diversity, equity & inclusion (36)
Drug discovery (104)
Drug pricing (103)
Drug shortages (15)
Duchenne muscular dystrophy (73)
Earnings (60583)
Editorial (26)
Employer branding (20)
Employer resources (130)
Events (98925)
Executive appointments (598)
FDA (15356)
Featured Employer (43)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (665)
Gene editing (76)
Generative AI (24)
Gene therapy (241)
GLP-1 (581)
Government (4602)
Grass and pollen (4)
Guidances (44)
Healthcare (18798)
Huntington's disease (14)
IgA nephropathy (15)
Immunology and inflammation (76)
Indications (26)
Infectious disease (2746)
Inflammatory bowel disease (116)
Inflation Reduction Act (10)
Influenza (49)
Intellectual property (73)
Interviews (331)
IPO (12922)
IRA (40)
Job creations (3007)
Job search strategy (1337)
Kidney cancer (6)
Labor market (25)
Layoffs (326)
Leadership (11)
Legal (5808)
Liver cancer (64)
Lung cancer (245)
Lymphoma (103)
Machine learning (2)
Management (52)
Manufacturing (238)
MASH (53)
Medical device (12620)
Medtech (12625)
Mergers & acquisitions (16524)
Metabolic disorders (541)
Multiple sclerosis (61)
NASH (15)
Neurodegenerative disease (62)
Neuropsychiatric disorders (16)
Neuroscience (1701)
NextGen: Class of 2025 (6511)
Non-profit (4828)
Northern California (2051)
Now hiring (28)
Obesity (285)
Opinion (190)
Ovarian cancer (63)
Pain (64)
Pancreatic cancer (68)
Parkinson's disease (114)
Partnered (20)
Patents (163)
Patient recruitment (87)
Peanut (44)
People (50423)
Pharmaceutical (52)
Pharmacy benefit managers (17)
Phase I (16502)
Phase II (22232)
Phase III (17515)
Pipeline (898)
Podcasts (49)
Policy (101)
Postmarket research (2420)
Preclinical (7700)
Press Release (69)
Prostate cancer (79)
Psychedelics (30)
Radiopharmaceuticals (229)
Rare diseases (294)
Real estate (5478)
Recruiting (61)
Regulatory (19304)
Reports (33)
Research institute (2603)
Resumes & cover letters (261)
Rett syndrome (3)
RNA editing (2)
RSV (33)
Schizophrenia (59)
Series A (115)
Series B (71)
Service/supplier (16)
Sickle cell disease (50)
Southern California (1761)
Special edition (15)
Spinal muscular atrophy (131)
Sponsored (31)
Startups (3227)
State (1)
Stomach cancer (5)
Supply chain (51)
The Weekly (28)
United States (18781)
Vaccines (665)
Venture capitalists (27)
Webinars (13)
Weight loss (172)
Women's health (32)
Worklife (13)
Date
Today (76)
Last 7 days (553)
Last 30 days (2272)
Last 365 days (30318)
2025 (7127)
2024 (31772)
2023 (35935)
2022 (46903)
2021 (51321)
2020 (50725)
2019 (45175)
2018 (33953)
2017 (28684)
2016 (29244)
2015 (34597)
2014 (27239)
2013 (23818)
2012 (24310)
2011 (24988)
2010 (23152)
Location
Africa (830)
Alabama (51)
Alaska (6)
Arizona (172)
Arkansas (13)
Asia (40717)
Australia (6874)
California (4653)
Canada (1699)
China (413)
Colorado (232)
Connecticut (256)
Delaware (115)
Europe (84503)
Florida (745)
Georgia (190)
Hawaii (1)
Idaho (56)
Illinois (468)
India (25)
Indiana (291)
Iowa (8)
Japan (138)
Kansas (86)
Kentucky (22)
Louisiana (9)
Maine (68)
Maryland (752)
Massachusetts (3550)
Michigan (216)
Minnesota (337)
Mississippi (2)
Missouri (82)
Montana (31)
Nebraska (24)
Nevada (51)
New Hampshire (61)
New Jersey (1463)
New Mexico (31)
New York (1434)
North Carolina (872)
North Dakota (8)
Northern California (2051)
Ohio (176)
Oklahoma (14)
Oregon (30)
Pennsylvania (1117)
Puerto Rico (6)
Rhode Island (24)
South America (1062)
South Carolina (19)
South Dakota (1)
Southern California (1761)
Tennessee (88)
Texas (688)
Utah (162)
Virginia (123)
Washington D.C. (58)
Washington State (476)
West Virginia (3)
Wisconsin (53)
621,772 Results for "quintiles hrs formerly health research solutions pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
Deals
Sentrex Health Solutions Inc. Expands Innovative Healthcare Services with Strategic Acquisition of PerCuro Clinical Research Ltd.
Sentrex Health Solutions Inc., a leading provider of specialty healthcare services in Canada, is excited to announce the acquisition of PerCuro Clinical Research Ltd.—one of Canada’s premier providers of infusion services, clinical research, and advanced nursing care.
February 12, 2024
·
2 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Press Releases
Nutex Health to Present at the EDPMA Solutions Summit 2025
March 20, 2025
·
3 min read
Press Releases
IncreMedical Therapy Solutions Rebrands as Confluent Health System Solutions to Advance Musculoskeletal Rehabilitation Services Nationwide
February 6, 2025
·
3 min read
Business
Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that its Australian subsidiary, Psyence Australia Pty Ltd. (“Psyence Australia”), has entered into a partnership with Fluence, a global leader in professional education and training for psychedelic therapy research, and iNGENū CRO Pty Ltd (“iNGENū”), an Australian clinical research organization (CRO), to support an upcoming Phase llb clinical trial.
April 8, 2024
·
8 min read
Press Releases
Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
February 27, 2025
·
6 min read
CARTHERICS ENTERS INTO COLLABORATIVE RESEARCH AGREEMENT WITH TICAROS
Cartherics Pty Ltd (“Cartherics”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it has entered a collaborative research agreement with TiCARos Co Ltd
April 2, 2024
·
4 min read
Press Releases
Onco-Innovations’ Inka Health Innovative AI-Driven Oncology Study Paves the Way for New Research
February 27, 2025
·
5 min read
BioMidwest
Research on Plant-Based SARS-CoV-2 Vaccine to Be Presented at One Health Symposium by PlantPharm BioMed
Dr. Richard Matner, President of PlantPharm BioMed, Ltd. will be presenting at the International Symposium on One Health Research: Improving Food Security and Resilience, in Galveston, Texas April 21–23, 2024.
April 15, 2024
·
2 min read
1 of 62,178
Next
